FACTOR 2025 Panel Highlights! 🩺FACTOR brings together the leading researchers, clinicians, and surgeons, along with patient families and OsteoWarriors (survivors, patients and siblings of OsteoWarriors and OsteoAngels) to Make It Better for those battling this disease. Speakers share new research, treatments, and hope. 🩺During the conference we have our Scientific Panels, HQ for Osteowarriors and their siblings, Wellness sessions and a Healing Hearts Bereavement workshop. 🩺Remember to register, time is running out! https://factor-2025.raiselysite.com/ #MIBAgents #MakeItBetter #osteosarcoma #FACTOR2025 #F25 (fb)

TODAY AT 5PM ET! 🧬We will be joined by Yingqi Hua, MD, PhD, on OsteoBites to discuss, "Molecular Subtyping of Osteosarcoma, ecDNA And More". 🧬Register for this webinar here: https://www.eventbrite.com/e/osteobites-welcomes-yingqi-hua-md-phd-tickets-1281928034259?aff=oddtdtcreator 🧬"I have been engaged in basic and clinical research of malignant bone tumors for more than 10 years, focusing on the individualized comprehensive treatment of advanced bone tumors, and is committed to transforming research results through clinical research. Research Interests: 1. Multi-omics study of osteosarcoma: Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment. 2. Epigenetic study of bone tumors: the function of histone mutation and the function of different histone methylation modification. 3. Drug screen: Screening sensitive drugs by patient derived xenograft(PDX) and explore the mechanism of drug action. 4. Clinical trial of advanced stage sarcomas based on precision medicine." #MIBAgents #MakeItBetter #osteosarcoma #OsteoBites #podcast (fb)